References

  1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020. Global burden of disease study. Lancet. 1997;349(9063):1498-1504. PubMed | Google Scholar

  2. Bonita R, Ford MA, Stewart AW. Predicting survival after stroke: A three-year follow-up. Stroke. 1988;19(6):669-673. PubMed | Google Scholar

  3. Cucchiara BL, Kasner SE, Wolk DA, et al. Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Crit Care Med. 2004;32(1):241-245. PubMed | Google Scholar

  4. Frankel MR, Morgenstern LB, Kwiatkowski T, et al. Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-pa stroke trial. Neurology. 2000;55(7):952-959. PubMed | Google Scholar

  5. Di Bonito P, Di Fraia L, Di Gennaro L, et al. Impact of known and unknown diabetes on in-hospital mortality from ischemic stroke. Nutr Metab Cardiovasc Dis. 2003;13(3):148-153. PubMed | Google Scholar

  6. Ogun SA, Ojini FI, Ogungbo B, Kolapo KO, Danesi MA. Stroke in south west Nigeria- A 10- year review. Stroke. 2005;36(6):1120-1122. PubMed | Google Scholar

  7. Belayev L, Busto R, Zhao W, Clemens JA, Ginsberg MD. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. J Neurosurg.1997;87(4):595- 601. PubMed | Google Scholar

  8. Belayev L, Zhao W, Pattany PM, Weaver RG, Huh PW, Lin B, Busto R, Ginsberg MD. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Stroke. 1998;29(12):2587-2599. PubMed | Google Scholar

  9. Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD. Human albumin therapy of acute ischemic stroke. Marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke. 2001;32(2):553-560. PubMed | Google Scholar

  10. De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P. A comparism of five stroke scales with measures of disability, handicap and quality of life. Stroke. 1993;24(8):1178-1181. PubMed | Google Scholar

  11. van Swieten JC, Koudsteal PJ, Visser MC, et al. Inter observer agreement for the assessment of handicap in stroke patient. Stroke. 1988;19(5):604-607. PubMed | Google Scholar

  12. WHO MONICA project principal investigators. The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major collaboration. J Clin Epidemiol. 1988;41(3):105-114. PubMed | Google Scholar

  13. Sulter G, Steen C, De Keyser J. Use of Barthel index and Modified Rankin Scale in acute stroke trials. Stroke. 1999;30(8):1538-1541. PubMed | Google Scholar

  14. Hankey JK, Jamrozik K, Broadhurst RJ et al. Long-term disability after first-ever stroke and related prognostic factors in The Perth Community Stroke Study 1989-1990. Stroke. 2002;33(4):1034-1040. PubMed | Google Scholar

  15. Abubakar SA, Yunusa GH, Isezuo SA. Predictors of 30 days outcome of patients with acute stroke in Sokoto. Sahel Medical Journal. 2010; 13 (2):68-73.. PubMed | Google Scholar

  16. Njoku CH, Aduloju AB. Stroke in Sokoto, Nigeria: Five year retrospective study. Annals of Afr Med. 2004;3(2):73-76. PubMed | Google Scholar

  17. Danesi MA, Oyenola YA, Ontiri AC. Risk factors associated with cerebrovascular accident in Nigeria (a case control study). EAMJ. 1983;60(3):191-195. PubMed | Google Scholar

  18. Gall SL, Donnan G, Dewey HM, Macdonell MD et al. Sex differences in presentation, severity, and management of stroke in a population based study. Neurology. 2010;74(12):975-981. PubMed | Google Scholar

  19. Di Carlo A, Lamassa M, Pracucci G et al. Stroke in the very old, clinical presentation and determinants of 3-month functional outcome: a European perspective. Stroke. 1999;30(11):2313-23. PubMed | Google Scholar

  20. He P, Curry FE. Albumin modulation of capillary permeability: role of endothelial cell [Ca2+]i. Am J Physiol. 1993; 265(1 Pt 2):H74-82. PubMed | Google Scholar

  21. Quinlan GJ, Martin GS, Evans TW. Albumin: Biochemical properties and therapeutic potential. Hepatology. 2005; 41(6): 1211-1219. PubMed | Google Scholar

  22. Dziedzic T, Slowik A, Szezudlik A. Serum albumin level as a predictor of ischaemic stroke outcome. Stroke. 2004;35(1):156-158. PubMed | Google Scholar

  23. Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J. Albumin level and stroke: Potential association between lower albumin level and cardioembolic aetiology. Int J Neurosci. 2011; 121(1): 25-32. PubMed | Google Scholar

  24. Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Thomassen L. Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study. Cerebrovasc Dis. 2009; 28(1): 13-7. PubMed | Google Scholar

  25. Franch-Arcas. The meaning of hypoalbuminaemia in clinical practice. Clin Nutr. 2001; 20(3):265-269. PubMed | Google Scholar

  26. Ginsberg MD.Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology. 2008; 55(3):363-89. PubMed | Google Scholar

  27. Ganiballa SE, Parker SG, Taub N, Castleden CM. Influence of nutritional status on clinical outcome after acute stroke. Am J Nutr. 1998;68(2): 275-281. PubMed | Google Scholar

  28. Davalos A, Ricart W, Gonzalez-Huix F, Soler S, Marrugat J, Molins A, Suner R, Genis D. Effect of malnutrition after acute stroke on clinical outcome. Stroke. 1996;27(6):1028-1032. PubMed | Google Scholar

  29. Alvarez-Perez FJ, Castelo-Branco M , Alvarez-Sabin J. Albumin level and stroke. Potential association between lower albumin level and cardioembolic aetiology .International Journal of neuroscience. 2011;121(1):25-32. PubMed | Google Scholar

  30. TT Idicula, U Waje-Andreassen, J Brogger, H Naess, L Thomass. Serum albumin in ischemic stroke patients: The higher the better. The Bergaenstro Cerebrovasc Dis. 2009;28(1):13-17. PubMed | Google Scholar

&n